Screening of antimycoplasma antibiotics.
D000666:Amphotericin B / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology; D001377:Azaserine / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D007933:Leucomycins / Q000494:pharmacology; D008937:Mitomycins / Q000494:pharmacology; D009174:Mycoplasma / Q000187:drug effects*; D009355:Neomycin / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D010303:Paromomycin / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D013302:Streptomyces
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D007933:Leucomycins; D008937:Mitomycins; D009840:Oligomycins; D011113:Polymyxins; D003609:Dactinomycin; D007612:Kanamycin; D010303:Paromomycin; D000666:Amphotericin B; D001377:Azaserine; D003523:Cycloserine; D009355:Neomycin; D004096:Dihydrostreptomycin Sulfate